Today: 10 June 2026
Gold price stock rally: GLD, Newmont climb after soft U.S. jobs data lifts bullion

Gold price stock rally: GLD, Newmont climb after soft U.S. jobs data lifts bullion

New York, Jan 9, 2026, 13:44 EST — Regular session

  • Gold-linked funds and miners rose after U.S. payrolls data came in below forecasts
  • Spot gold held near record levels as traders weighed the rate outlook and fresh policy risk
  • Focus turns to U.S. Supreme Court tariff rulings on Jan. 14 and the Fed’s Jan. 27-28 meeting

SPDR Gold Shares (GLD) rose 0.3% to $412.88 in midday trading on Friday, while major U.S.-listed gold miners also moved higher. Newmont gained 1.4%, Agnico Eagle Mines climbed 2.2% and Franco-Nevada advanced 3.1% as investors pushed back into bullion-linked names.

Spot gold — the cash price for immediate delivery — was up 0.6% at $4,502.98 an ounce by 11:18 a.m. ET, after the nonfarm payrolls report, the closely watched U.S. jobs release that excludes farm workers. Bullion was set for a weekly gain of more than 4% and has hovered near a record high of $4,549.71 hit on Dec. 26. “Payrolls are showing us a poor job creation environment,” said Bart Melek, global head of commodity strategy at TD Securities. Reuters

The rate angle is doing most of the work. Gold pays no interest, so it tends to look better when investors expect lower borrowing costs, though traders shifted toward a longer pause after the jobs report showed the unemployment rate dipped to 4.4% even as hiring slowed. Olu Sonola, head of U.S. economic research at Fitch Ratings, said hiring was “stuck in stall speed,” even if the jobless rate eased pressure on the Federal Reserve. Reuters

Trade policy is the other live wire. The U.S. Supreme Court is scheduled to issue rulings on Jan. 14, with investors watching for any decision tied to the legality of President Donald Trump’s sweeping global tariffs, a case that has become a broader test of presidential power.

Miners add their own twist because earnings can swing more than the metal itself when costs move or operations stumble. Agnico Eagle said on Thursday it will release fourth-quarter and full-year 2025 results on Feb. 12 after normal trading hours.

Newmont is expected to report on Feb. 19, based on Nasdaq’s earnings calendar, and investors will be watching for updates on production, costs and 2026 guidance after a sharp run in gold prices.

But the same leverage cuts the other way. HSBC said this week it sees a wide 2026 trading range of $5,050 to $3,950 an ounce and warned a correction later in the year could deepen if geopolitical risks fade or if the Fed stops cutting rates.

The next hard date for the gold trade is the Fed’s Jan. 27-28 meeting, where any shift in the policy path could ripple quickly through the dollar, yields and the gold price — and into gold stocks.

Stock Market Today

  • Dollar Index Edges Up as Oil Prices Surge and Stocks Decline
    June 10, 2026, 5:59 PM EDT. The dollar index rose slightly by 0.06% on Wednesday, recovering from early losses. A more than 2% surge in WTI crude oil prices raised inflation expectations, supporting the U.S. dollar amid concerns over potential Federal Reserve monetary tightening. The U.S. May Consumer Price Index matched forecasts, with inflation still at a three-year high. Concurrently, geopolitical tensions between the U.S. and Iran increased safe-haven demand for the dollar. In Europe, the euro gained modestly amid expectations of a European Central Bank interest rate hike, though oil price gains restricted upside. The Japanese yen fell to a five-week low against the dollar, pressured by rising crude prices and U.S. Treasury yields, despite hawkish signals from Japan's producer price data and central bank.

Latest articles

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

Parabilis Medicines (PBLS) soars 58% after $670 million IPO beats range

10 June 2026
Parabilis Medicines soared 58% above its $20 IPO price to close at $31.60 in its Nasdaq debut after raising a record $670 million, reflecting strong investor demand for its Helicon drug platform ahead of a pivotal Phase 3 desmoid tumor trial planned for 2027; Regeneron’s $75 million private placement added credibility.
Joby Aviation Shares Slip After CFO Files to Sell Stock

Joby Aviation Shares Slip After CFO Files to Sell Stock

10 June 2026
Joby Aviation fell 4.47% to $8.86 after CFO Rodrigo Brumana disclosed selling 78,489 shares under a prearranged 10b5-1 plan, with no new certification or commercial-launch updates, leaving investors focused on regulatory progress and cash burn as the key catalysts for the stock.
YY Group Shares Spike as Humanoid Robot Plans Unveiled

YY Group Shares Spike as Humanoid Robot Plans Unveiled

10 June 2026
YY Group Holding shares surged to $0.165 on heavy volume after announcing a commercial humanoid-robotics initiative using Unitree G1 robots and facility-management data, reframing the company as a robotics-and-AI data play; the rally comes despite 2025 net loss, dilution risk from a relaunched at-the-market share-sale program, and no disclosed robot-related revenue or contracts.
Nokia stock rises after Hisense patent deal ends litigation; investors watch next moves
Previous Story

Nokia stock rises after Hisense patent deal ends litigation; investors watch next moves

Kohl’s stock slides 5% as tariff ruling delay hits retailers; KSS traders eye Jan. 14
Next Story

Kohl’s stock slides 5% as tariff ruling delay hits retailers; KSS traders eye Jan. 14

Go toTop